Alexion To Join With AZ Ahead Of US Soliris Biosimilars In 2025

Originator Shifting Patients To Next-Gen Ultomiris

 
• By Dean Rudge
PumpkinPie
Amgen is aiming to get a slice of the US eculizumab market in 2025 with a biosimilar launch. • Source: Shutterstock

More from Biosimilars

More from Products